Medindia
Medindia LOGIN REGISTER
Advertisement

CSL Behring Receives FDA Approval to Extend Shelf Life for Privigen(R) from 24 to 36 Months

Monday, April 19, 2010 General News
Advertisement
Increases convenience, ease of use for primary immunodeficiency patients and health providers

Contact:

Greg Healy, Senior Manager, Communications & Public Relations

U.S. Commercial Operations

CSL Behring

610-878-4841

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close